Revvity unveils a new era of automated tuberculosis testing

The new platform promises to substantially lower hands-on time, allowing for increased lab productivity

28 Apr 2024
Lawrence Howes
Editorial Assistant

Revvity has launched the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is designed to be easy to use and provide efficient lab workflows. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians, and ultimately patients, benefit from the resultant powerful solution.

The Auto-Pure 2400 liquid handler for use with the T-SPOT.TB test:

  • The Auto-Pure 2400 automated liquid handling platform is equipped with integrated magnetic cell isolation technology.
  • Designed for testing up to 24 samples per run, it completes day-1 T-SPOT.TB workflows in under 3.5 hours, requiring only a single mid-run user interaction.
  • The solution simplifies lab workflows and has an intuitive software user interface.

The T-SPOT.TB test:

  • The T-SPOT.TB test detects latent tuberculosis infection (LTBI) and is an interferon-gamma release assay (IGRA) based on the enzyme-linked immunospot (ELISPOT) technology.
  • This technology has crucial steps that the World Health Organization has recently recognized as critical in ensuring reliable and accurate TB test results. These steps include washing, isolating, and counting peripheral blood mononuclear cells (PBMCs) before conducting the test.

Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>